
Stage-Gate Process in New Product Development (NPD)
Category: Article | Category: Whitepaper
Thursday, September 28, 2017
The Stage-Gate process can be defined as a framework where large innovation programmes are divided into phases (stage).
Category: Article | Category: Whitepaper
Thursday, September 28, 2017
The Stage-Gate process can be defined as a framework where large innovation programmes are divided into phases (stage).
Monday, September 11, 2017
Pfizer recently signed an agreement with Teva Pharmaceuticals, in which Teva can begin to market the US’ first generic version of the drug from December 2017.
Wednesday, August 9, 2017
Collaboration between IP & R&D departments can be very difficult as they come from different worlds.
Thursday, August 3, 2017
Jurgen Vollrath, President of Exponential Technology Counsel, on NDAs.
Wednesday, July 5, 2017
Intangible assets now make up 80 percent of a business' value.
Category: Article | Category: eBook
Tuesday, May 2, 2017
The top 50 food manufacturers account for 20 percent of global packaged food retail sales.
Category: Article | Category: Whitepaper
Monday, March 20, 2017
Why should you care if someone is infringing on your patents or, even worse, what could happen if you infringe on someone else's?
Category: Article | Category: eBook
Thursday, March 16, 2017
The indicator approach is a qualitative consideration of a patent’s value which looks at certain distinctions in the features of a patent.
Category: Article | Category: eBook
Thursday, March 9, 2017
With certain IP, such as trademarks, value can actually increase over time as the brand grows in stature.
Category: Article | Category: Whitepaper
Thursday, March 9, 2017
The market value approach attempts to assign a value of an asset on the open market based on information from similar market transactions.
Category: Article | Category: eBook
Saturday, March 4, 2017
The income approach is the most popular method of patent valuation.
Friday, January 27, 2017
It is becoming important for startups to protect their work and stay ahead of competition by protecting their assets through various forms of IP.
Category: Article | Category: eBook
Wednesday, January 25, 2017
Patentability of software is a tricky subject as the variations from country to country are less than clear.
Wednesday, January 11, 2017
Although biotech and pharma both produce drugs, they do so in different ways and have a different basis.
Category: Article | Category: eBook
Thursday, November 3, 2016
There is a prevailing view within much of the software industry that it is simply not worth the bother to patent.
Monday, October 17, 2016
Obsolescence management is still a relatively nascent topic for many organizations.
Category: Article | Category: Whitepaper
Monday, October 10, 2016
It is clear which is the bigger of the two companies and this disparity is reflected in a comparison of their patent portfolios.